BioFlorida’s 25th Annual Conference united statewide leaders of Florida’s life sciences industry representing biopharmaceutical, medical technology, and digital health companies, globally recognized research universities and research institutions, and the state’s health systems to spotlight the continued momentum and success in science, business, and public policy and spur collaboration and future growth.
“For 25 years, BioFlorida has convened our state’s champions for the life sciences – those leaders from Florida-based companies, research institutions, and health systems – to spotlight success, to foster collaboration, and to explore policy solutions to fuel continued industry growth and innovation,” said Nancy K. Bryan, President and CEO of BioFlorida. “The Conference provided an opportunity to reflect on the role we’ve played to collectively establish Florida as a leading life science destination that today represents 8,600 establishments and research organizations that employ nearly 107,000 Floridians. But our focus remains on the patient, and we’re excited to continue the unprecedented collaboration to develop new, innovative treatments and cures over the next 25 years.”
The Conference explored topics ranging from emerging therapies and breakthrough research in cancer care, rare disease, neurology and movement disorders, and gene and cell therapy to innovations in manufacturing, financing strategies, commercialization considerations, and other emerging trends, like AI and machine learning applications and leveraging MedTech to improve the patient, physician, and clinical experience. All conversations were led by CEOs, executives and top scientists and researchers from Florida-based companies, universities, research organizations, and health systems.Learn more about Florida’s Life Science Leaders United To Celebrate 25 Years of Innovation and Growth in the State